Evidence map›Paper›PMID 42452267›Full record

ReviewPlants (Basel, Switzerland)2026

Application of Nanoparticles in Plant In Vitro Culture for Micropropagation and Secondary Metabolite Production: A Review.

Natalia A Semenova, Dmitry A Zakharov, Dmitry A Serov, Sergey V Gudkov, Alexey S Dorokhov, Andrey Yu Izmailov

Abstract readReview
In one paragraph

Review in Plants (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Natalia A SemenovaProkhorov General Physics Institute, Russian Academy of Sciences, Vavilov Str. 38, 119991 Moscow, Russia.ORCID 0000-0003-4132-7256
Dmitry A ZakharovProkhorov General Physics Institute, Russian Academy of Sciences, Vavilov Str. 38, 119991 Moscow, Russia.ORCID 0009-0005-7584-0295
Dmitry A SerovProkhorov General Physics Institute, Russian Academy of Sciences, Vavilov Str. 38, 119991 Moscow, Russia.ORCID 0000-0002-6049-5602
Sergey V GudkovProkhorov General Physics Institute, Russian Academy of Sciences, Vavilov Str. 38, 119991 Moscow, Russia.ORCID 0000-0002-8814-6906
Alexey S DorokhovFederal Scientific Agroengineering Center VIM, 109428 Moscow, Russia.
Andrey Yu IzmailovFederal Scientific Agroengineering Center VIM, 109428 Moscow, Russia.

Funding

Ministry of Science and Higher Education of the Russian Federation 075-15-2024-540
6 · The paper itself

Abstract

This review summarizes recent studies on the use of nanoparticles (NPs) in plant in vitro clonal micropropagation and secondary metabolite production. The analyzed applications include culture initiation, shoot multiplication, rooting, acclimatization, callus culture, and hairy root culture. Because NPs' effects are strongly endpoint-dependent, their effectiveness is evaluated separately for micropropagation endpoints, including contamination control, explant survival, multiplication rate, shoot and root development, and plantlet quality, and for metabolite-production endpoints, including biomass accumulation, target metabolite concentration, and total metabolite yield. Based on the quantitative analysis of published data, the most frequently beneficial NP size range was 20-60 nm, whereas effective concentrations, combining a positive effect on plant growth and the synthesis of secondary metabolites, were mainly within 1-120 mg L

Indexed as

elicitationexplant sterilizationhairy root culturein vitro rootingmicropropagationnanoparticlesplant tissue culturesecondary metabolitesshoot multiplication

Identifiers

PMID42452267
PMCPMC13364071

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.